Open Beta
MetriLume

US marketsBMRA

SEC-sourced researchBeta

BMRA

BIOMERICA INC

Company comparison ↗

Data passport

CIK
0000073290
Exchange
Nasdaq
Business activity
In Vitro & In Vivo Diagnostic Substances · SIC 2835
Financial inputs
6/6
Filing date
Oct 16, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: May 2025: 5,311,000.0000 USD; May 2026: 4,453,000.0000 USD5.3M USD0 USD0May 2025May 2026
BMRA · Exact amounts and source periods · USD
Period endRevenueFiling date
May 20255,311,000.0000Aug 31, 2026
May 20264,453,000.0000Aug 31, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
May 20264,453,000.0000-3,775,000.0000-3,421,000.00006,759,000.00004,129,000.0000Aug 31, 2026
May 20255,311,000.0000-4,973,000.0000-3,842,000.00005,945,000.00001,840,000.0000Aug 31, 2026

Explainable fundamental score

Five equally weighted components based on SEC financial inputs. No price inputs or personal investment preferences.

35/100
Profitability0
Growth34
Balance sheet39
Cash generation0
Data coverage100

Component weight: 20% · Minimum data coverage: 50% · Missing component value: 50/100

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$4.45MJun 1, 2025 – May 31, 2026Aug 31, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$5.31MJun 1, 2024 – May 31, 2025Aug 31, 202610-K
Net incomeNetIncomeLoss-$3.78MJun 1, 2025 – May 31, 2026Aug 31, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$3.42MJun 1, 2025 – May 31, 2026Aug 31, 202610-K
Total assetsAssets$6.76MMay 31, 2026Aug 31, 202610-K
Total liabilitiesLiabilities$4.13MMay 31, 2026Aug 31, 202610-K

New filings

Explore methodology ↗